Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1PRN1008 (Rilzabrutinib)
(D11873)		1件: Rilzabrutinib1件: Rilzabrutinib (D11873) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 35 💬
2Rilzabrutinib
(D11873)		1件: Rilzabrutinib1件: Rilzabrutinib (D11873) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬6件: 35, 61, 63, 222, 223, 300 💬
3Rilzabrutinib Oral Tablet
(D11873)		1件: Rilzabrutinib1件: Rilzabrutinib (D11873) 💬 1件: BTK 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬1件: 35 💬